• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.79% Nasdaq Up 0.16%

    XOMA Corporation (XOMA)

    -NasdaqGM
    3.48 Down 0.02(0.57%) Jan 23, 4:00PM EST
    |After Hours : 3.45 Down 0.03 (0.86%) Jan 23, 5:19PM EST
    Add to Portfolio
    Prev Close:3.50
    Open:3.51
    Bid:N/A
    Ask:3.51 x 300
    1y Target Est:8.83
    Beta:4.64
    Earnings Date:Mar 2 - Mar 6 (Est.)
    Day's Range:3.35 - 3.52
    52wk Range:3.25 - 9.57
    Volume:2,781,404
    Avg Vol (3m):2,778,950
    Market Cap:373.73M
    P/E (ttm):N/A
    EPS (ttm):-1.12
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    XOMADown 0.57%373.73M
    NVSUp 0.03%234.30B
    REGNDown 0.14%42.36B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):13.89
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.48
    Quarterly EPS Est (Dec-14) :-0.13
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):-0.38

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    XOMA Corporation discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific. Its proprietary products comprise gevokizumab, a humanized allosteric-modulating monoclonal antibody that binds to the inflamma... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback